BD 2651915 - PowerLoc PAK Safety Infusion Set, 19G x 1.5", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2651915 - PowerLoc PAK Safety Infusion Set, 19G x 1.5", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2651915 PowerLoc PAK Safety Infusion Set is a sterile, single-use port-access solution designed for accessing compatible surgically implanted vascular ports. The set features a 19-gauge non-coring needle with a 1.5-inch length and is configured without a Y-injection site, providing a direct fluid pathway for compatible infusion and vascular-access procedures.

The PowerLoc system supports administration of compatible fluids and medications, blood specimen withdrawal, implanted port flushing, and power injection through appropriately rated vascular access systems. The 19-gauge configuration provides a larger fluid pathway for procedures requiring higher flow capability, while the 1.5-inch needle length accommodates implanted ports positioned beneath a greater depth of subcutaneous tissue.

An integrated passive needle-tip safety mechanism is designed to help reduce accidental needlestick exposure during port deaccessing. As the needle is withdrawn, the safety system helps shield and secure the sharp point before handling and final disposal.

The winged PowerLoc design provides a compact, low-profile footprint that supports dressing application, access-site visibility, stabilization, and routine patient care. Its power-injectable design makes the device suitable for appropriately rated implanted port systems used in both infusion therapy and compatible diagnostic imaging workflows.

The PAK presentation provides an organized, all-in-one approach intended to simplify the multi-step sterile preparation process for implanted port access. BD 2651915 is supplied five sets per case.

Key Benefits

• 19-gauge non-coring needle supports access to compatible implanted vascular ports.
• 1.5-inch needle length accommodates ports positioned beneath greater subcutaneous tissue depth.
• Larger 19-gauge fluid pathway supports applications requiring higher flow capability.
• Power-injectable design supports compatible contrast-enhanced diagnostic imaging procedures.
• Compatible 19-gauge PowerLoc configurations support power-injection flow rates up to 5 mL per second when the complete system is appropriately rated.
• Configuration without a Y-injection site provides a direct, streamlined fluid pathway.
• Non-coring needle design helps minimize unnecessary damage to the implanted port septum during appropriate use.
• Passive needle-tip safety mechanism helps protect against accidental needlestick exposure during deaccessing.
• Winged configuration supports controlled insertion, stabilization, and removal.
• Low-profile design helps facilitate dressing application and routine access-site management.
• Small footprint supports visibility around the implanted port access site.
• Suitable for compatible infusion therapy, blood sampling, port maintenance, and power-injection procedures.
• PAK configuration helps organize supplies used during sterile port-access preparation.
• Five-per-case packaging supports efficient clinical inventory management.

Compatibility and Applications

The BD 2651915 PowerLoc PAK Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential clinical applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood product administration, long-term infusion therapy, blood specimen collection, implanted port flushing, and contrast-media delivery during compatible diagnostic imaging procedures.

The 19-gauge configuration may be selected when higher flow capability is required and the implanted port, prescribed therapy, and complete fluid pathway are compatible with a larger-gauge access needle. Selection should consider fluid viscosity, medication requirements, desired flow rate, infusion equipment, port specifications, and professional clinical judgment.

The 1.5-inch needle length is intended for implanted ports located beneath a greater depth of tissue. Correct needle-length selection is important because a needle that is too short may not fully access the port septum, while unnecessary additional length may affect stability and dressing placement.

This configuration does not include a Y-injection site. It may therefore be appropriate for workflows in which a direct connection is preferred and secondary medication or fluid access through the infusion tubing is not required.

For power injection, the implanted port, access needle, tubing, connectors, and every other component in the complete fluid pathway must be appropriately rated for the intended procedure. The lowest-rated component determines the maximum allowable operating pressure and flow rate.

Compatibility should be confirmed with the exact implanted port model, septum design, port depth, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access procedures.

Usage Guidelines

The BD 2651915 should be used only by healthcare professionals trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status when applicable.
• Assess the location and depth of the implanted port before selecting the 1.5-inch needle.
• Verify that the 19-gauge configuration is appropriate for the intended therapy or imaging procedure.
• Confirm that a configuration without a Y-injection site is suitable for the planned clinical workflow.
• Inspect the sterile package for damage, moisture, punctures, contamination, or compromised integrity.
• Prepare the implanted port site according to institutional antisepsis and sterile-access procedures.
• Prime the complete infusion pathway with an approved solution before port access.
• Remove air from the fluid pathway before connecting the device to the implanted port.
• Stabilize the implanted port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate contact with the base of the port reservoir is achieved.
• Verify appropriate placement according to institutional policy, including aspiration for blood return when clinically indicated.
• Flush the implanted port according to current manufacturer instructions and facility protocol.
• Position and secure the tubing to minimize pulling, twisting, pressure, and dressing disruption.
• Apply an approved sterile dressing while maintaining appropriate access-site visibility.
• Monitor the access site for pain, swelling, redness, leakage, displacement, or other abnormalities.
• Confirm the power-injection status of the complete system before connecting a power injector.
• Do not exceed 5 mL per second or the lower operating limit of any component within the complete system.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and allowing the safety mechanism to engage.
• Confirm that the needle is secured in the protective position before further handling.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the port-access system if unexpected resistance occurs during flushing, appropriate blood return cannot be obtained when expected, the patient reports unusual discomfort, or swelling, leakage, or another abnormality develops at the access site.

Certifications and Safety Standards

The BD 2651915 PowerLoc PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The device should be incorporated into facility procedures addressing implanted port assessment, hand hygiene, sterile preparation, skin antisepsis, port access, infusion administration, dressing management, power injection, deaccessing, and sharps disposal.

The integrated passive needle-tip safety feature is designed to help protect healthcare professionals from accidental needlestick exposure during removal of the device from an implanted port.

The safety mechanism does not replace appropriate clinician training, personal protective equipment, safe sharps-handling practices, exposure-control procedures, or immediate disposal of the used device in an approved sharps container.

The non-coring needle is designed for accessing compatible implanted vascular port septa. Needle gauge and length should be selected according to patient anatomy, tissue depth, implanted port specifications, prescribed therapy, required flow characteristics, and current manufacturer instructions.

Healthcare organizations should verify current manufacturer documentation for applicable FDA clearance, UDI information, sterilization method, material composition, natural rubber latex status, DEHP information, shelf life, maximum pressure, flow-rate specifications, and other technical or regulatory requirements.

Comparison with Competitors

Compared with conventional implanted port needles without integrated safety technology, the BD PowerLoc system incorporates passive needle-tip protection designed to help reduce accidental needlestick exposure during deaccessing and disposal.

Compared with port-access sets containing a Y-injection site, BD 2651915 provides a direct fluid pathway without an additional secondary access point. This can simplify the tubing configuration when secondary medication administration is not required.

Compared with non-power-injectable port-access needles, the PowerLoc platform is designed to support compatible power-injection procedures when used with an appropriately rated implanted port and complete fluid pathway.

Compared with 20-gauge and 22-gauge PowerLoc configurations, the 19-gauge needle provides a larger fluid pathway and may be preferred when higher flow capability is clinically required. Gauge selection should always be based on the implanted port, prescribed procedure, patient needs, and system compatibility.

Compared with 0.75-inch and 1-inch access needles, the 1.5-inch configuration is intended for implanted ports positioned beneath greater tissue depth. Correct length selection helps support complete septum access, stability, and appropriate dressing placement.

Compared with loose individual port-access supplies, the PAK presentation provides an organized solution for the multi-step sterile preparation process. This can help streamline supply preparation and promote greater procedural consistency.

Alternative safety infusion sets may vary in gauge, needle length, power-injection capability, safety activation method, tubing design, Y-site availability, included kit components, and package quantity. BD 2651915 combines a 19-gauge, 1.5-inch non-coring needle with power-injection capability, passive needle-tip safety, a no-Y-site configuration, and organized PAK presentation.

Typical User Profile and Application Scenarios

The BD 2651915 PowerLoc PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified healthcare personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other healthcare facilities where implanted vascular ports are routinely accessed.

The product may be selected for patients whose implanted port requires a longer 1.5-inch access needle because of port position or tissue depth and whose prescribed therapy or diagnostic procedure is compatible with a 19-gauge device.

Typical application scenarios include chemotherapy administration, antibiotic infusion, hydration, parenteral nutrition, blood product administration, blood specimen collection, implanted port maintenance, and power injection of contrast media during compatible imaging procedures.

The configuration without a Y-injection site is particularly suitable for clinical workflows that use a direct infusion connection and do not require a secondary access point within the tubing.

Best Practices for Use and Maintenance

The BD 2651915 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on proper storage, accurate product selection, sterile preparation, port-access technique, access-site monitoring, safety activation, and disposal.

• Store unopened sets according to the environmental conditions specified by the manufacturer.
• Protect packages from moisture, excessive temperature, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2651915 catalog number before opening the package.
• Confirm the 19-gauge size, 1.5-inch needle length, and configuration without a Y-injection site.
• Assess the patient's tissue depth and implanted port position before selecting the needle length.
• Confirm that the prescribed therapy, fluid characteristics, and required flow rate are appropriate for a 19-gauge device.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the entire fluid pathway before accessing the implanted port.
• Stabilize the port during both needle insertion and removal.
• Position the tubing to minimize pulling, twisting, or pressure at the access site.
• Monitor the implanted port site and tubing connections throughout therapy.
• Verify that the entire access system is appropriately rated before any power-injection procedure.
• Never exceed the lowest pressure or flow-rate limit of any component within the system.
• Do not bend, cut, modify, repair, or otherwise alter the infusion set.
• Do not reuse, clean, resterilize, or reprocess the single-use device.
• Confirm complete safety activation immediately following needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2651915 PowerLoc PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 19-gauge size, 1.5-inch needle length, no-Y-site configuration, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every component within the complete fluid pathway are specifically rated for the intended procedure. Permitted pressure, flow rate, contrast-media characteristics, and other operating conditions must be confirmed before use.

Compatible 19-gauge PowerLoc configurations support power injection up to 5 mL per second under applicable manufacturer-specified conditions. The lowest-rated component within the complete system determines the maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may contribute to infiltration, extravasation, leakage, tissue injury, implanted port damage, interrupted therapy, or other complications.

Because BD 2651915 does not include a Y-injection site, it does not provide an additional secondary access point within the tubing. Clinical teams should confirm that a direct fluid pathway meets the requirements of the planned therapy.

The safety mechanism should be used according to current manufacturer instructions. The device remains a contaminated sharp after deaccessing and should be discarded immediately in an approved sharps container.

BD 2651915 is supplied five sets per case. Distributor listings identify this configuration as temperature sensitive and non-returnable. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, order quantity, and applicable return conditions before purchasing.

How to Order

Select the BD 2651915 - PowerLoc PAK Safety Infusion Set without Y-Injection Site, 19G x 1.5" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.